GRAPEFRUIT COMPONENT INTERACTING WITH RAT AND HUMAN P450 CYP3A - POSSIBLE INVOLVEMENT OF NONFLAVONOID COMPONENTS IN DRUG-INTERACTION
Citation
K. Fukuda et al., GRAPEFRUIT COMPONENT INTERACTING WITH RAT AND HUMAN P450 CYP3A - POSSIBLE INVOLVEMENT OF NONFLAVONOID COMPONENTS IN DRUG-INTERACTION, Biological & pharmaceutical bulletin, 20(5), 1997, pp. 560-564
Categorie Soggetti
Pharmacology & Pharmacy
SICI code
0918-6158(1997)20:5<560:GCIWRA>2.0.ZU;2-Q
Abstract
Active components in grapefruit juice, which modulate a cytochrome P45
0 (CYP3A) activity, were investigated. CYP3A-catalyzed 6 beta-hydroxyl
ation of testosterone in livers of rat and human was inhibited by the
addition of an ethyl acetate-extract of grapefruit juice. Several comp
onents of grapefruit juice, including naringin, naringenin, limonin an
d obacunone, also showed inhibitory effects in human liver microsomes.
However, the amounts of these components in grapefruit juice are too
low to account for the inhibition by the ethyl acetate-extracts. Analy
ses with HPLC indicate the existence of inhibitory components in the e
xtract, which are distinct from these known compounds and are specific
to grapefruit juice. These results suggest that hydrophobic component
s other than flavonoids, probably coumarin derivatives, are responsibl
e for the inhibitory effect of grapefruit juice.